AMBRISENTAN SANDOZ 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
AMBRISENTAN SANDOZ 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Pending
Register Number
84715
Prescription Type
Uso Hospitalario
Authorization Date
Dec 10, 2019
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number84715
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
AMBRISENTANActive
Quantity: 5 mg
Name: AMBRISENTAN
ATC CLASSIFICATION (3)
C02K
C02KX
C02KX02